QR kȏd

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 DegradationSUMMARY

Background & Aims: The contribution of abnormal metabolic targets to hepatocellular carcinoma (HCC) progression and the associated regulatory mechanisms are attractive research areas. High-density lipoprotein binding protein (HDLBP) is an important transporter that protects cells from excessive...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Jingsheng Yuan, Tao Lv, Jian Yang, Zhenru Wu, Lvnan Yan, Jiayin Yang, Yujun Shi, Li Jiang
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2023-01-01
Serija:Cellular and Molecular Gastroenterology and Hepatology
Teme:
Online pristup:http://www.sciencedirect.com/science/article/pii/S2352345X22002168
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!